Intrinsic Value of S&P & Nasdaq Contact Us

LFTD Partners Inc. LSFP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
46/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

LFTD Partners Inc. (LSFP) generated $969.75B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $44.49B, free cash flow was $925.26B.

Free cash flow margin was 2.5% of revenue. Cash conversion ratio was -0.04x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (52/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -0.04x suggests some earnings are non-cash items

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
25/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
52/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
LFTD Partners Inc. Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $969.75B$969.75B$699.05K$-265.61K$351.75K
Capital Expenditure $-44.49B$-44.49B$-2.53K$-7.4K$-77.15K
Free Cash Flow $925.26B$925.26B$696.51K$-273.01K$274.6K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message